(Q43589125)

25 November 2017

title

Remodeling of ventricular repolarization in a chronic doxorubicin cardiotoxicity rat model (English)

1 reference

25 November 2017

1 reference

Sergey Kharin

1

1 reference

25 November 2017

Valeria Krandycheva

2

1 reference

25 November 2017

Alena Tsvetkova

3

1 reference

25 November 2017

Marina Strelkova

4

1 reference

25 November 2017

Dmitry Shmakov

5

1 reference

25 November 2017

publication date

19 March 2012

1 reference

Fundamental and Clinical Pharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

27

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

364-372

1 reference

Adriamycin-induced heart failure: mechanism and modulation

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Molecular and cellular mechanisms of anthracycline cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Cardiovascular and survival effects of sympatho-inhibitors in adriamycin-induced cardiomyopathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Myocardial strain analysis in a doxorubicin-induced cardiomyopathy model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving mice. A new model to test potential protectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Effects of doxorubicin on excitation-contraction coupling in guinea pig ventricular myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Electrophysiological changes in animal model of chronic cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Chronic doxorubicin induced cardiomyopathy in rabbits: mechanical, intracellular action potential, and beta adrenergic characteristics of the failing myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Effects of autologous bone marrow stem cell transplantation on beta-adrenoceptor density and electrical activation pattern in a rabbit model of non-ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Monophasic action potentials and activation recovery intervals as measures of ventricular action potential duration: Experimental evidence to resolve some controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Molecular physiology of cardiac repolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Electrophysiological remodeling in hypertrophy and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

DNA damage is an early event in doxorubicin-induced cardiac myocyte death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Current perspectives of electrical remodeling and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Alterations of pre- and postsynaptic noradrenergic signaling in a rat model of adriamycin-induced cardiotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Ionic basis of ventricular arrhythmias in remodeled rat heart during long-term myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Normal regional distribution of membrane current density in rat left ventricle is altered in catecholamine-induced hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

TVP1022 protects neonatal rat ventricular myocytes against doxorubicin-induced functional derangements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Continuous electrocardiogram reveals differences in the short-term cardiotoxic response of Wistar-Kyoto and spontaneously hypertensive rats to doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Early and late arrhythmogenic effects of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Recent advances in understanding sex differences in cardiac repolarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Electrotonic influences on action potential duration dispersion in small hearts: a simulation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Cardiotoxicity of anticancer treatments: what the cardiologist needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

Usefulness of cardiac resynchronization therapy in the management of Doxorubicin-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2012.01037.X

10.1111/J.1472-8206.2012.01037.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference